HIV Drug Resistance to Dolutegravir Among Adults Investigated for Antiretroviral Treatment Failure in Malawi: A 2023 National Cross-Sectional Survey.

Saved in:
Bibliographic Details
Title: HIV Drug Resistance to Dolutegravir Among Adults Investigated for Antiretroviral Treatment Failure in Malawi: A 2023 National Cross-Sectional Survey.
Authors: Kalata NL; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi., Bello G; International Training and Education Centre for Health, University of Washington, Lilongwe, Malawi., Pals S; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA., Kabaghe AN; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi., Mkungudza J; International Training and Education Centre for Health, University of Washington, Lilongwe, Malawi., Bighignoli B; International Training and Education Centre for Health, University of Washington, Lilongwe, Malawi., Panja L; International Training and Education Centre for Health, University of Washington, Lilongwe, Malawi., Bilaal W; Directorate of HIV, Hepatitis and Syphilis, Ministry of Health, Lilongwe, Malawi., Kusakale G; International Training and Education Centre for Health, University of Washington, Lilongwe, Malawi., Chitenje M; International Training and Education Centre for Health, University of Washington, Lilongwe, Malawi., Luhanga M; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi., Zeh C; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA., Kampira E; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi., Chipeta S; Directorate of HIV, Hepatitis and Syphilis, Ministry of Health, Lilongwe, Malawi., Mvula B; Directorate of HIV, Hepatitis and Syphilis, Ministry of Health, Lilongwe, Malawi., Nyirenda R; Directorate of HIV, Hepatitis and Syphilis, Ministry of Health, Lilongwe, Malawi., Jahn A; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA., Kagoli M; Directorate of HIV, Hepatitis and Syphilis, Ministry of Health, Lilongwe, Malawi., Maida A; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi., O'Malley G; International Training and Education Centre for Health, University of Washington, Seattle, Washington., van Oosterhout JJ; Partners in Hope, Lilongwe, Malawi.; Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA., Agyemang E; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA., Zheng DP; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA., Hackett S; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA., Raizes E; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA., Wadonda N; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi., da Silva J; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA.
Source: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2025 Dec 01; Vol. 100 (4), pp. 364-370.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 100892005 Publication Model: Print Cited Medium: Internet ISSN: 1944-7884 (Electronic) Linking ISSN: 15254135 NLM ISO Abbreviation: J Acquir Immune Defic Syndr Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1944-7884
DOI:10.1097/QAI.0000000000003744